Clinical Trial Update: Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2) [NA]

View source ↗

Summary

Update on the completed LUTEGA 2 trial evaluating the long-term effects of lutein, zeaxanthin, and omega-3 supplementation on age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lutein (lutein)
• Omega-3 fatty acids (omega-3 fatty acids)
• Zeaxanthin (Zeaxanthin)

Snippet

Sponsor: University of Jena | Conditions: Age Related Maculopathy | NA | Status: COMPLETED